Literature DB >> 16564785

Endothelial dysfunction in PCOS: role of obesity and adipose hormones.

E Carmina1, F Orio, S Palomba, R A Longo, T Cascella, A Colao, G Lombardi, G B Rini, Rogerio A Lobo.   

Abstract

PURPOSE: Polycystic ovary syndrome (PCOS) is an extremely prevalent disorder in which elevated blood markers of cardiovascular risk and altered endothelial function have been found. This study was designed to determine if abnormal carotid intima-media thickness (IMT) and brachial flow-mediated dilation (FMD) in young women with PCOS may be explained by insulin resistance and elevated adipocytokines.
METHODS: A prospective study in 50 young women with PCOS (age: 25.2 +/- 1 years; body mass index [BMI]: 28.7 +/- 0.8) and 50 matched ovulatory controls (age: 25.1 +/- 0.7 years; BMI: 28.5 +/- 0.5) was performed. Carotid IMT, brachial FMD, and blood for fasting glucose, insulin, leptin, adiponectin and resistin were measured.
RESULTS: PCOS, IMT was increased (P <.01), FMD was decreased (P <.01), fasting insulin was increased (P <.01), QUICKI (a marker of insulin resistance) was decreased (P <.01), and adiponectin was lower (P <.05), whereas leptin and resistin were not different compared with matched controls. Whereas BMI or waist/hip ratios did not correlate with IMT or FMD, insulin and QUICKI correlated positively and negatively with IMT (P <.01). There was a significant negative correlation between adiponectin and IMT (P <.05). These correlations were unchanged when adjusting for BMI and the correlation between IMT and adiponectin was unaffected by insulin resistance parameters.
CONCLUSIONS: These data suggest that young women with PCOS have evidence for altered endothelial function. Adverse endothelial parameters were correlated with insulin resistance and lower adiponectin. Both insulin resistance and adiponectin appear to be important parameters. It is hypothesized that the type of fat distribution may influence these factors. Copyright 2006 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564785     DOI: 10.1016/j.amjmed.2005.10.059

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  34 in total

Review 1.  [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].

Authors:  D Heutling; H Schulz; H Randeva; C Dodt; H Lehnert
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

2.  Birth weight and childhood growth in daughters of women with irregular menstrual cycles.

Authors:  Erica T Wang; Piera M Cirillo; Chia-Ning Kao; Barbara A Cohn; Marcelle I Cedars
Journal:  Gynecol Endocrinol       Date:  2013-06       Impact factor: 2.260

3.  Varying patterns of brachial artery flow-mediated dilatation in women with polycystic ovary syndrome and controls: An application of the group-based trajectory modeling.

Authors:  Michelle L Meyer; Ping G Tepper; Emma Barinas-Mitchell; Mary T Korytkowski; Evelyn O Talbott
Journal:  J Clin Ultrasound       Date:  2015-07-14       Impact factor: 0.910

Review 4.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

5.  Ovarian hypertension: polycystic ovary syndrome.

Authors:  Rhonda Bentley-Lewis; Ellen Seely; Andrea Dunaif
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

6.  Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.

Authors:  Maheswari Thangavelu; Usha Rani Godla; F D Paul Solomon; Ravi Maddaly
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

Review 7.  Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Michelle L Meyer; Angela M Malek; Robert A Wild; Mary T Korytkowski; Evelyn O Talbott
Journal:  Hum Reprod Update       Date:  2011-11-22       Impact factor: 15.610

8.  Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.

Authors:  L J Moran; C Meyer; S K Hutchison; S Zoungas; H J Teede
Journal:  J Endocrinol Invest       Date:  2009-10-15       Impact factor: 4.256

9.  Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training.

Authors:  V S Sprung; D J Cuthbertson; C J A Pugh; C Daousi; G Atkinson; N F Aziz; G J Kemp; D J Green; N T Cable; H Jones
Journal:  J Physiol       Date:  2013-01-14       Impact factor: 5.182

10.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.